By FnF Correspondent | PUBLISHED: 22, Mar 2021, 19:29 pm IST | UPDATED: 22, Mar 2021, 19:29 pm IST
In India, Bharat Biotech's Covaxin and Serum Institute of India's Covishield have been approved by the Centre for emergency use. Both vaccines are being used in India's vaccination drive. However, the revised interval applies only to Covishield.
Reason Why Centre Is Increasing Interval for Second Jab of Covishield -
"In view of the emerging scientific evidence, the interval between two doses of a specific COVID-19 vaccine, Covishield, has been revisited by the National Technical Advisory Group on Immunization (NTAGI) and subsequently by National Expert Group on Vaccine Administration for COVID-19," the letter said.
India has witnessed a sudden surge in positive Covid-19 cases in the last few days.
According to the Union health ministry data, the nation on Monday recorded 6,951 new Coronavirus positive cases in the last 24 hours, highest so far in the last 4 and a half months, taking the total COVID-19 tally to 1,16,46,081.
by : Priti Prakash
After Xi Jing Ping has sealed his lifetime chairmanship of the Communist Party its for him to delive...